Thomas Illmer, Markus Schaich, Gerhard Ehninger, Christian Thiede. Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias. haematol [Internet]. 2007Jan.1 [cited 2024Apr.28];92(1):137-8. Available from: https://haematologica.org/article/view/4295